Connect Biopharma Holdings Limited Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income
Connect Biopharma Holdings Limited (CNTB) had Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income of $0 as of 2023-12-31, per its 20-F filed 2024-04-16.
Discontinued › Notes › Equity
ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome · last filed 2024-04-16
- 2022-12-31: Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income 65.74M CNY.
- 2022-06-30: Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income 149.68M CNY.
CNY
| Period end | Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income |
|---|---|
| 2022-12-31 | 65.74M CNY 6-K · filed 2023-09-12 |
| 2022-06-30 | 149.68M CNY 6-K · filed 2022-09-13 |
USD
| Period end | Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-16 |
| 2022-12-31 | $9.44M 20-F · filed 2024-04-16 |
| 2022-06-30 | $22.30M 6-K · filed 2022-09-13 |
| 2021-12-31 | $0.00 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |